Associated Papers
Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population.
Arun AS et al.
The Pharmacogenomics Journal, 2025
40044654 (PubMed )
Supplement: 41397_2025_364_MOESM3_ESM.xlsx › Sheet1
Patients with genetically heterogeneous synchronous colorectal cancer carry rare damaging germline mutations in immune-related genes.
Cereda M et al.
Nature Communications, 2016
27377421 (PubMed )
Supplement: ncomms12072-s2.xlsx › UH2T1
Systematic analysis of somatic mutations in phosphorylation signaling predicts novel cancer drivers.
Reimand J et al.
Molecular Systems Biology, 2013
Sodium ion channel mutations in glioblastoma patients correlate with shorter survival.
Joshi AD et al.
Molecular Cancer, 2011
Select a paper to view details